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Summary 
Microglia, a type of tissue macrophage, are the only cells in the central nervous system (CNS) 
parenchyma to express some major histocompatibility complex (MHC)  class II constitutively 
or to upregulate expression readily. They are thought to play a role in CD4 T  cell activation in 
autoimmune  diseases  such  as  multiple  sclerosis,  as well  as  in  neurodegenerative  conditions, 
Alzheimer's disease in particular. We show here that highly purified MHC class II  + micro- 
glia when tested directly ex vivo do indeed support an effector response by an encephalitogenic 
myehn basic protein-reactive CD4 T  cell line from which production of the proinflammatory 
cytokines, interferon ~/and tumor necrosis factor, is elicited, but not interleukin  (IL)-2 secre- 
tion or proliferation. After this interaction,  the T  cells  die by apoptosis. Other nonmicroglial 
but CNS-associated macrophages isolated in parallel stimulate full T  cell activation, Including 
IL-2 production,  proliferation, and support T  cell survival. Neither CNS-derived population 
expresses BT.1/B7.2. Resident macrophages that terminate effector T  cells in tissues  constitute 
a novel and broadly applicable regulatory measure of particular relevance to processes of self- 
tolerance against sequestered antigens. 
A 
ll  tissues,  including  those  previously believed  to  be 
privileged  sites  such  as  the  central  nervous  system 
(CNS) 1, are subject to immunological surveillance via non- 
antigen-dependent extravasation of activated T  cells. Thus, 
activated but not resting T  cells with specificity for either 
foreign or self antigen penetrate the blood-brain barrier which 
enables them not only to "patrol" CNS tissue for organisms 
like viruses but also to initiate local autoimmune responses 
(1). The elimination ofT cells in tissues is considered an es- 
sential  protective  sequel  to  antigen  encounter  (2,  3),  but 
the cellular interactions that underlie this process as well as 
those involved in initial antigen presentation and T  cell ac- 
tivation in the CNS remain ill-defined. 
The demonstration that microglial cells (MG) rather than 
astrocytes were  the  major parenchymal  cells  of the  CNS 
expressing MHC class II in multiple sclerosis  (4), in experi- 
mental autoimmune encephalomyelitis (EAE [5]), as well as 
constitutively (6-8)  resulted in attention being focused on 
this cell as the premier APC for subsequent antigen recog- 
nition  by extravasating T  lymphocytes. Additionally,  MG 
MHC class II expression in neurodegenerative diseases such 
as Alzheimer's disease  (6)  has been  a  major piece  of evi- 
1Abbreviations used in th~s  paper" CNS. central nervous system; EAE, exper- 
imental autmrnmune encephalomyelms;  MBP, myehn basic protein; MG, 
mlcroghal cells. 
dence  cited  in  support  of the  proposal  that  such  diseases 
may have an underlying immunological/inflammatory path- 
ogenesis. A synergistic interaction between [3-amyloid pro- 
tein, IFN-~/(predominantly a T  cell cytoklne), and MG, in 
induction  of neuronal  cell damage in vitro,  has also been 
reported (9). 
Nevertheless,  the  argument  that  MG  are  an  important 
stimulator of both primary and secondary T  cell responses 
in the  CNS  and  the  experimental evidence in  support  of 
this  concept  (10,  11),  is  inconsistent  with  a  number  of 
pieces of experimental data, namely: (a) The observed pau- 
city of activated or proliferating T  cells in the parenchyme 
of inflamed CNS  (12,  13)  in which  a  network  of MHC 
class II  + MG can normally be found; (b) MG constitutively 
express  MHC  class  II  most  highly  in  the  EAE-resistant 
Brown Norway rat strain  (8);  and  (c) intra-CNS  adminis- 
tration  of IFN-~/, while  strongly upregulating  MG MHC 
class II expression, inhibits or reduces the severity of EAE 
(14),  while anti-IFN-~ mAb treatment enhances EAE  se- 
verity (15). 
To  resolve  this  issue,  activated  MG  were  purified  by 
flow cytometric sorting from the adult CNS (16,  17) to en- 
able immediate ex vivo analysis of the APC role of MHC 
class lI  + MG for myelin basic protein (MBP)-reactive CD4 
T  cell responses. We show here that MG support only an 
incomplete form of T  cell activation and induce apoptotic 
death of the responding T  cells. 
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Antibodies and Flow Cytometry.  Mouse  mAb  for  flow  cyto- 
memc sorting and analysis were MRC  OX1  (anti-CD45  mono- 
morphic),  MILC  OX6  (anti-MHC  class  II),  MILC  OX42  (ann- 
CD11b and c), R73  (anti-0t/[3 TCR), W3/25  (anti-CD4), MtLC 
OX12  (ann-rat  Ig  K  chain),  MP,.C  OX39  (ann-CD25),  and 
MRC  OX40  (OX40  antigen  (TNFl:(/nerve  growth  factor  re- 
ceptor family).  MR.C  OX21  (mouse  anti-human  C3bi  and  not 
rat  cells),  K1-21  (mouse  anti-human  free  K-light  chain  non- 
cross-reactive  with  rat  Ig)  and mouse anti-human  CD4-PE  (Se- 
rotec,  Oxford,  UK)  served as negative  controls.  See  (12,  18-21) 
for reference or cross-reference details. PE-conjugated OX1  (anti- 
CD45)  and  P,.73  (anti-c~/[3  TCR)  were  from  Pharmingen,  San 
Diego,  CA.  For darect staining,  mAb were purified,  then conju- 
gated to  either FITC or biotin.  Biotinylated mAb were detected 
with  either  streptawdin-PE  (two-color  flow  cytometry;  Caltag 
Laboratories,  San Francisco,  CA) or streptavidm-allophycocyanln 
(three-color  flow  cytometry;  Molecular  Probes,  Eugene,  OR). 
For flow cytometry m  which mouse mAb nssue culture supema- 
tants  were  used,  mAb  were  detected  with  rat-absorbed  FITC- 
conjugated sheep  F(ab')2 anti-mouse Ig (Slgrna Chemical Co.,  St. 
Louis,  MO).  CTLA-4-Ig  derived  from  the  hybndoma  cell  line 
J558L  transfected  with  the  mouse  CTLA-4/human  IgG1  fusion 
protein  DNA construct  (22),  was  ~solated from culture superna- 
rant by protein G-Sepharose (Pharmacla, Uppsala, Sweden) affin- 
ity chromatography,  and blotinylated.  Two-color flow cytomet- 
nc  analysis  was  performed  on  a  FACScan  ® (Becton  Dickinson 
and Co.,  San Jose,  CA) whtle three-color analysis or sorting was 
executed with a dual-laser FACStar  etUs® (Becton Dickinson  and 
Co.). 
G I/WD Induaion and Cell Isolation.  GVHD was reduced in 2 Gy 
y-irradiated adult Brown Norway  X  Lewis strain  (F1) rats by m- 
]ectmn 1.v. of 2  X  108 Lewis strain splenocytes.  10 d after spleno- 
cyte injection, ammals were killed, perfused extensively, the CNS 
removed  from  the  GVHD-affected  as  well  as  from  normal  F1 
rats,  and MG and CNS-assoclated  macrophages/leukocytes pun- 
fled to homogeneity by sorting, as described (17). 
Assays for T  Cell Activation and Apoptosis  For each  experiment, 
MG  from  day-10  GVHD  F1  rats  and  CD45 h`g" macrophages 
from the normal F1  rat  CNS  were  ~solated by sta, ning and flow 
cytomemc  sorting from  two  groups  of four to  six perfused  rats. 
Post-sort  purities  were  always  m  excess  of 95%.  Average  yields 
(per rat)  of wable cells after sorting were 3.5  ×  105 GVHD-acu- 
vated  microglia  and  4  ×  i04  normal  CNS  rnacrophages.  These 
CNS APC were resuspended m  P,  PMI  1640-5%  FCS and added 
immediately  to  wells  of a  96-well  U-bottom  micronter  plate. 
Cells were used on the day oflsolation and never precultured be- 
fore use.  Results were  tdentical whether CNS APC  were irra&- 
ated  (20  Gy-y) before  culture with  T  cells,  or not.  Normal LN 
cells as control APC were isolated from F 1 rats, and irradiated (20 
Gy-y).  Lewis  rat  strain  encephahtogenlc  (EAE-mducing)  MBP- 
specific  or  OVA-specific  CD4  T  cell  lines  (23)  were  added  to 
CNS-derived  or  LN  APC  together  wath  either  whole  purified 
guinea pig MBP  (15  btg/ml final concentranon)  +  IL-2  (saturat- 
ing concentrations),  the 68-86  encephalitogemc peptide of MBP 
(5  Ixg/ml),  OVA  (40  bLg/ml),  or  no  anngen.  Subsequent  treat- 
ments  were:  (a)  At  24  h,  supernatants  were  taken  for  cytokine 
analysis. Cytokine assays were: TNF - WEHI  164 cell cytotoxic- 
ity  (24)  IL-2-CTLL  bioassay  (25);  IFN-~/-rat  IFN-~/  ELISA 
(Glbco BRL,  Gaithersburg,  MD).  Units were  determined by ti- 
tration  against  recombinant  cytokmes in  each  case.  (b)  The  cul- 
tures were left for 48 h  and pulsed with 0.5  btCl [3H]thymid,ne/ 
well  for  harvest  14  h  later  and  measurement  of  proliferation 
(cpm).  Quahtatively  similar  results  were  obtained  using  culture 
times of 60 h  +  14 h  [3H]thymidine pulse.  (c) At 24 h, cells were 
recovered from the wells, washed, recultured for a further 24 h in 
RPMI  1640-5%  FCS  ___  IL-2,  then  fixed,  permeabllized  and 
double-stained  for  c~/[3TCR  and  for  apoptonc  cells  (FITC- 
dUTP)  by  the  TUNEL  technique  (Cell  Death  Detection  Kit; 
Boehnnger Mannhmm GmbH, Mannheim,  Germany).  For est> 
mation of apoptosis by flow cytometry, a live scatter gate was ap- 
phed to reduce the contribution to analys~s, of any TUNEL-pos- 
rove  cells  dying  by  necrosis.  (d)  At  24  h,  cells  were  recovered 
from the wells, washed, and recultured for a further 48 h with IL-2. 
These partially rested cells were added to wells coated with antl- 
ot/[3TCR mAb or an isotype-matched control mAb, and prolifer- 
ative responses assessed  by  [3H]thyrmdine incorporation  after 48 h 
total incubation time. 
In  Vitro B Cell Activation.  Flat-bottom  96-well  nssue  culture 
plates  (Costar Corp.,  Cambridge,  MA)  were  coated with rat  Ig- 
absorbed  rabbit  ann-mouse  lgG by additmn  of 50  I.zl/well anti- 
body (100 la.g/ml m PBS) and overnight incubation at 4°C. Wells 
were washed three times with PBS and  50 l.zi/welI mouse mAb 
tissue culture supematant specific for rat lg K chain added for 1-2 h 
at  37°C.  The  anti-rat  Ig-coated  wells  were  washed  thoroughly 
with PBS and dissocmted rat spleen cells m  RPMI  1640 (Cytosys- 
terns,  Sydney,  Austraha)-10%  FCS  (Trace,  Sydney,  Australia) 
added and cultured for a total of 48 h. B cell blasts were apparent 
within  24  h.  Cells  were  recovered  from  the  culture  plates  and 
stained for flow cytometry. 
MicrogliaI Cell Culture.  Highly  purified  MG  from  GVHD- 
affected  rat  CNS  were  cultured  on  t~ssue  culture  grade  plastic 
(Costar  Corp.),  m  RPMI  1640-5%  FCS.  Cultures  were  main- 
tamed in a 5% CO2 atmosphere at 37°C. 
Results  and Discussion 
Flow Cytometric Purification of Microglia  and CD45 h'gh CNS 
Macrophages.  Macrophage  lineage  cells  in  the  adult  CNS 
consisting of intraparenchymal  long-lived, irradiation-resis- 
tant fixed-tissue  macrophages  (or microglia,  Fig.  1,  A  and  B, 
CD451°wCD11b/c +,  population  1)  (26)  and  transient,  ves- 
sel-associated blood-derived  macrophages  (Fig.  1, A  and  B, 
CD45h'ghCDllb/c  +,  population  2),  were  separated  on  the 
basis  of CD45  expression  levels  (16).  The  distinct  nature 
and  anatomical  location  of  these  populations  have  been 
demonstrated  in  irradiation  bone  marrow  chimeras  in 
which  substantial turnover only of the CD45"'ghCDllb/c  + 
(non-MG)  population  from blood-derived  precursors  is ob- 
Figure 1.  Flow cytometnc separation  of CNS macrophage-hneage cells. (A) Flow cytometnc plots of MG/leukocyte-ennched populations from the 
CNS of normal healthy control rats or rats with GVHD at day l i). (B) Intraparenchymal MG (populatiotl I) are separated anatomically from blood-derived 
macrophages (population 2). (C) May-Gninwald Glemsa-stamed cytospins of these populanons isolated &rectly from the normal CNS by flow cytometrlc 
sorting using the well-separated sorting gates 1 and 2. (D) Freshly isolated GVHD-actavated MG cultured for the rimes shown. (Arrow) SDked processes 
Wpxcal for MG. Phase contrast microscopy. Bars' (C) 10 )tm; (D) 15 }xm. 
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Figure 2.  T cell acuvatlon with mlcrogllal cell APC  Surface phenotype ofMBP-reacUve CD4 T lymphocytes after MG culture. MBP-speclfic CD4 
T cell lines were cultured alone, or together with MG punfied from day 10 GVHD F1 rats (l:1 ratio), for 24 h with or without added MBP. Cells were 
recovered from the culture wells and dual labeled for CD1 lb/c and rather o~/13 TCP,, CD4, CD25, or MRC OX40. The phenotype only of the CD4 T 
cell hnes added to culture was assessed  by electromcally  gating-out CD1 lb/c  + cells (MG). For forward scatter, dotted hnes m the n-addle  and lower boxes 
represent the profile of T cells cultured alone  Other histograms  illustrate the surface antigen expressmn of the T cells (solid  histograms,  mean fluorescence 
indicated) and autofluorescence of the same cells stamed with lsotype-matched control mAb (dotted hnes) 
served  (17,  27).  Cytologically, the  two  populations  were 
quite distinct on isolation (Fig. 1  C). MG exhibited a typi- 
cal  heterochromatic  nucleus  and  lacked  the  cytoplasmic 
granules of conventional CNS macrophages. 
In GVHD,  T  cell blasts but few if any blood monocytes 
enter the CNS  (28) in a manner more reminiscent of nor- 
mal T  cell patrolling of the  CNS  than  inflammatory CNS 
disease like EAE. By flow cytometric sorting and immuno- 
histological analysis of MG  and CNS  tissue from rats with 
GVHD  we have shown  that MG  are activated directly by 
these infiltrating T  cells (Ford, A.L., E.  Foulcher, and J.D. 
Sedgwick, manuscript submitted for publication). MG  in- 
creased in number by up to six times, their levels of CD45 
expression were raised three- to fourfold (Fig. 1 A, popula- 
tion  3)  and all MG  up-regulated MHC  class II  (Fig.  1 A). 
CD45highCD1 lb/c + cells (population  2) were not clearly de- 
fined in  the  GVHD  CNS  and were  reduced numerically, 
possibly reflecting the radiation of the recipient preparatory 
to induction of GVHD.  The relative lack of inflammatory 
macrophages permitted a  clear distinction to be made  be- 
tween activated MG  (Fig. 1 A, sort gate 3) and other CNS 
macrophages.  MG  sorted from  the  GVHD-affected  CNS 
were  comparable morphologically to  those  obtained from 
the  normal CNS  (Fig.  1  C)  apart from an increase in  cell 
volume of~10%.  Unlike MG from the normal CNS  (17), 
GVHD-activated  MG,  when  cultured,  adhered  to  plastic 
within a few hours, developed many processes, and became 
highly motile (Fig. 1 D). The cells also phagocytosed 1 tim 
latex beads  (Ford, A.L.,  E.  Foulcher,  and J.D.  Sedgwick, 
manuscript submitted for publication). 
Microglia  Support  an  Incomplete  Form  of T  Cell  Activation. 
The  APC  potential  of MG  was  examined  by  culturing 
MBP-reactive  CD4  T  cells  in  the  presence  of activated 
freshly isolated MHC  class II  +  MG.  A  rapid antigen-spe- 
cific increase in the size ofT  cells from MG/T  cell cultures 
containing  MBP  was  detected  both  microscopically and 
flow cytometrically in the  form  of a  shift in forward light 
scatter  (Fig.  2).  This  was  accompanied  by  phenotypic 
changes  in  the  T  cells, with  some reduction  in  ot/[~TCR 
and CD4 expression and substantial up-regulation of CD25 
(IL-2R or-chain) and OX40  antigen expression. The  OX40 
antigen  is  up-regulated upon  CD4  T  cell activation  (20). 
The expression of CD25  and MRC  OX40  on T  cells cul- 
tured alone reflects some residual expression of these anti- 
gens and is typical for CD4 T  cell lines in culture. The mi- 
nor down-regulation ofo~/[3TCR expression and threefold 
increase in OX40 expression obtained in the absence of an- 
tigen (Fig. 2) may indicate some level of constitutive MBP 
presentation to  T  cells. Activated microglia are known  to 
phagocytose myelin in vivo (29). 
Consistent with previous studies on the role of non-MG 
CNS  macrophages  in  antigen  presentation  both  in  vivo 
(30) and in vitro (17), CD45 hIgh macrophages from the nor- 
mal CNS supported vigorous antigen-specific T  cell prolif- 
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Figure  3.  Production of effector T  cell cytokines but not T  cell prohf- 
eratlon with mlcroghal cell APC.  (A)  Proliferation of 104  MBP-reacUve 
CD4  T  cells m  the  presence  of 104  GVHD-acnvated  MG,  104  normal 
(CD45 h'gh) CNS macrophages, or 2.5  ×  10  s LN cells. Bars are mean cpm 
of triphcate detern~natmns  +  1 SD  and are representative of four  other 
similar experiments. *Proliferation oft  cells m  these cultures without an- 
tigen was significantly greater than that of all other controls without anti- 
gen (P <0.05, paired t test).  (/3) Cytokme content of supematants derived 
from cultures of MBP-reactlve CD4 T  cells in response to APC and anti- 
gen additives as indicated. Cell numbers per well as above. Tlters are units 
per milliliter of tissue culture supematant. The definition of units for each 
cytoklne is different. Bars are mean cpm of tnphcate  (TNF/IL-2)  or du- 
phcate (IFN-3')  detenmnatlons +  range from the mean and are represen- 
tative of two other slrmlar experiments. 
eration (Fig. 3 A), as did irradiated LN APC (positive con- 
trol).  The T  cell proliferation  observed with  normal  CNS 
macrophages in the absence  of added antigen  (asterisk)  was 
reproducible  and probably indicates  constitutive  presenta- 
tion of in vlvo-derived MBP.  A  single study was also per- 
formed  using  rare  CD45  high  macrophages  derived  from 
GVHD  CNS  and  these  cells,  like  those  from the  normal 
CNS,  supported  T  cell proliferation  (not shown).  MG,  in 
contrast,  failed  to  elicit  a  significant  proliferative  response 
above that obtained with T  cells alone. Neither addition of 
IL-2 (Fig.  3  A), nor varying the MG'T  cell ratios  two- to 
threefold,  reversed  this  lack  of responsiveness.  An impor- 
tant,  albeit  negative,  result,  was  that  MBP  T  cells  stimu- 
lated with  LN APC and antigen in tissue  culture supema- 
tants (75% final concentration)  derived from a 48-h culture 
of MG  alone  or a  48-h  culture  of MG,  CD4 T  cells,  and 
antigen,  proliferated  normally  relative  to  culture  in  fresh 
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medium  (not shown). Despite the failure to induce signifi- 
cant T  cell proliferation,  antigen-specific induction of both 
TNF and IFN-y (Fig. 3/3) occurred in the presence of MG 
at levels  comparable  to  that produced by T  cells  cultured 
with  CD45  h'gh CNS-derived macrophages.  The most pro- 
found difference  in  terms  of cytokine production was  the 
lack  of detectable  IL-2  in  supernatants  from  MG/T  cell 
cultures  (Fig. 3  B). 
These  experiments  show  that  antigen  presentation  by 
MG  produces  an  incomplete  form  of T  cell  activation, 
without IL-2 secretion or proliferation but with proinflam- 
matory cytokine production enabled.  The inability of MG 
to support proliferation after the addition of exogenous IL-2 
distinguishes this process from IL-2 reversible T  cell anergy 
seen after antigen presentation  in the absence of appropri- 
ate  costimulation  (31).  The  process is  not one of immune 
deviation (32), involving as it does, MG interaction with an 
already  fully  differentiated  type  1  CD4  +  effector  T  cell 
which, other than loss of IL-2 production, continues to ex- 
hibit  type  1  cytokine  characteristics  in  that  secretion  of 
TNF  and  IFN-y is  preserved  (Fig.  3  B).  The  inability  of 
MG/T  cell-conditioned supernatant  to inhibit  T  cell pro- 
liferation provides no evidence for the role of secreted fac- 
tors in mediating T  cell unresponsiveness.  Thus it is likely 
that direct MG--T cell interactions are responsible. 
Microglia hlduce  T  Cell Apoptosis.  To  study  the  down- 
stream  consequences  of T  cell-MG  interaction,  T  cells 
were  stimulated  with  antigen  for 24  h  in  the  presence  of 
MG and cultured for a further 24 h in medium (Fig 4 A,/). 
In these  cultures,  apoptosis was detected  in ¢'-'20% of the 
T  cell population.  Apoptotic T  cells  expressed lower levels 
of ci/[3 TCP,.  By contrast,  no apoptotic changes were ob- 
tained in T  cells  that were cultured alone or in the presence 
of other APC.  T  cells  cultured  together  with  CNS  mac- 
rophages and antigen  at the same ratio  (1:1) as used in the 
MG  cultures  underwent  full  T  cell  activation  (Fig.  3)  but 
no apoptosis  (Fig.  4  A,  it). These results  therefore  demon- 
strate  that it was the MG and not simply the induction of 
T  cell  activation  (producing,  for example,  T  cell-T  cell- 
mediated apoptosis [33]), that was important in this process. 
Addition of IL-2 for 24 h  after culture with MG  (Fig. 
4  A, I/) resulted in almost complete rescue of T  cells  from 
MG-induced  apoptotic  death.  As noted  earlier  (Fig.  3  A), 
addition of exogenous IL-2 to MG/T  cell cultures did not 
promote  proliferation  of T  cells  despite  the  fact that  they 
expressed the IL-2 receptor at high levels (Fig. 2). The abil- 
ity of exogenous IL-2 to act as a survival factor for T  cells 
after  culture  with  MG  effectively excludes  the  possibility 
that the expressed  IL-2 receptor was nonfunctional.  Thus, 
this  mechanism  differs  from the  reversible  state  of T  cell 
unresponsiveness  induced by the  interaction  of lung mac- 
rophages with  activated T  cells in which  IL-2 production 
was  reported  to be  maintained  but  signal  transduction  via 
the IL-2 receptor was defective (34). 
Apoptosis appeared to be antigen dependent since its in- 
cidence  was  much  lower  in  MG/T  cell  cultures  lacking 
antigen (Fig. 4 A,  111, 5.4% vs 19.7%). The residual level of 
apoptosis seen in the absence of added antigen was presum- A  Antigen/IL-2 
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Figure 4.  Microgha APC but not other CNS macrophages  induce IL-2-reverslble apoptosls and anergy in CD4 T cells (A) Anngen-speclfiC  apoptos]s 
in CD4 T lymphocytes cultured m the presence of MG. Culture conditions were as per Fig. 3. Numbers  are percent  TUNEL-posmve ot/13TCR  + 
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CD4 T lymphocyte lines to TCR cross-hnklng after MG or LN APC culture (+ specific  antigen) and 48 h IL-2 rescue (as per group II cells  in A but with 
an adchuonal  24 h of IL-2) Bars represent means of mphcate determinations. Magnitude of T cell prohferatmn on immobilized ojf3TCP, mAb of cells 
preexposed to LN APC vs MG, was slgmficantly  less in each case (OVA 1, P <0.05.  MBP.2, P <0.01.  Paired t test). 
ably  due  to  constitutive  MG  presentation  of  (in  vivo- 
derived)  MBP.  Consistent  with  this  possibility is  the  en- 
hanced  expression of the  OX40  antigen noted previously 
(Fig. 2). Controls using CNS macrophages without antigen 
(Fig. 2,  C  and  D)  were  not performed due  to  the limited 
numbers  of CD45 high CNS  macrophages available. In any 
event, even in the presence of antigen, apoptosis of T  cells 
cultured with CD45 h'gh CNS macrophages was minimal. 
IL-2-rescued  T  Cells  Fail  to  Respond  to  TCR  Cross-Link- 
ing.  IL-2 is a  recognized T  cell survival factor  (35)  that, 
particularly in secondary T  cell responses, is associated with 
increased production of Bcl-XL and Bcl-2 survival proteins 
(36).  The  capacity of IL-2 to rescue T  cells from apoptosis 
(Fig. 4 A, I/) has important implications for the pathogene- 
sis of CNS disease. In particular, its secretion by other T  lym- 
phocytes  recruited  to  the  site  during  inflammation  could 
reverse apoptosis, thereby enabling a response from T  cells 
that  were  destined for termination.  In  the  context  of au- 
tolmmune inflammation, this would be an undesirable out- 
come.  Such  a  possibility was  examined  by  determining 
whether proliferative activity of T  cells preexposed to MG 
and specific antigen and "rescued" with IL-2 could be re- 
stored by cross-linking with an anti-ot/~3TCR mAb (Fig. 
4  B). According to  the results, MBP  T  cells (as well as an 
OVA-reactive CD4 T  cell line included to test the univer- 
sality of the effect) responded poorly to this stimulus when 
the level of  proliferation was compared with T  cells derived 
from  cultures containing LN APC.  A  third MBP-reactive 
T  cell line gave a qualitatively identical response (not shown). 
Thus,  IL-2-rescued T  cells remained functionally anergic, 
at least on the basis of this assay. By analogy with anergic B 
and T  cells in vivo, which exhibit shortened life spans rela- 
tive  to  normal  resting  lymphocytes  (2),  the  anergic  state 
observed here may simply represent delayed death.  Such a 
scenario in fact makes good sense, since persistence of pop- 
ulations of anergic T  cells in tissues is of no obvious advan- 
tage to the host,  and is consistent with previous reports of 
apoptotlc T  lymphocytes in CNS inflammation (37, 38). 
G VHD-activated Microglia and  CD45  h'~'h CNS Macrophages 
Are B7.1/B7.2  Negative.  The  outcome  of the  encounter 
between  T  cells and antigen  described here  is determined 
entirely  at  the  level  of the  APC.  A  possible  explanation 
would be expression ofcostimulatory molecules by CD45 h'gh 
macrophages but not MG.  Occasional cells in the multiple 
sclerosis CNS  (39)  and in in vitro-maintained human MG 
(40)  reportedly are B7  positive. Here,  however,  a  CTLA- 
4-Ig fusion  protein  that  strongly labeled rat  B  cell blasts 
(Fig. 5 A, population 2)  but not T  cells (Fig. 5 A,  popula- 
tion  1)  or resting B  cells (not shown)  failed to  detect B7.1 
(CD80)  or B7.2  (CD86)  expression on freshly isolated MG 
or CD45 high CNS macrophages from the normal (Fig. 5  B) 
and  GVHD-affected  CNS  (Fig.  5  C).  Note  that  when 
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48 h on munobihzed anu-rat *< chain mAb to activate  B cells  (population  2) 
Population 2 was >90%  B cell blasts, most macrophages remaining at- 
tached to the culture wells. (B and C) Freshly isolated MG (populations 3 
and 5) and other CNS macrophages (populations 4 and 6). Solid histo- 
grams show B7.1 and B7 2 expression assessed  using blotmylated CTLA- 
4-Ig. Dotted histograms represent the background fluorescence of desig- 
nated populations stained with blotlnylated human IgG. 
stained only with a negative control reagent (dotted  lines), a 
5-10-fold increase in background fluorescence displayed by 
MG  and  other CNS  macrophages  (populations 3-6)  rela- 
tive to  T  cells and B  cell blasts (populations  I  and  2)  was 
observed.  MG,  like other macrophages  are  known  to  ex- 
press Fc  receptors and  also  are  more  autofluorescent  than 
lymphocytes.  These  factors  in  combination  may  account 
for the background staining. Control experiments in which 
cultured  splenocytes  were  exposed  to  the  same  enzyme 
treatment  as  that  used  to  isolate cells from  the  CNS  (17) 
showed that CTLA-4-Ig binding to B  cell blasts was main- 
tained. 
Concluding Remarks.  The processes responsible for elim- 
ination of potentially autoreactive T  and B  cells, both dur- 
ing  development  and  after activation in  lymphoid tissues, 
are increasingly well defined (33, 41). The role oflympho- 
cyte Fas-FasL interactions is of particular importance. It has 
been speculated that mechanisms must also exist for termi- 
nation of effector T  cells in nonlymphoid tissues after anti- 
gen encounter (2, 3), although evidence for this and defini- 
tion  of the  actual  processes  involved  remains  limited.  In 
inflammation,  the  increased  density of T  cells  and  blood 
monocytes  entering tissues,  including the  CNS  through  a 
disrupted blood brain barrier, may facilitate T  cell regula- 
tion (33,  42)  and potentially, at least, Fas-FasL interactions 
may participate. However, under conditions where T  cells, 
including those  with self specificity, traffic into  and patrol 
normal  tissues,  it should  not  be  assumed  that  apoptosis is 
mediated solely by interactions  involving FasL  (33)  given 
that FasL expression appears quite restricted on resident tis- 
sue cells (43,  44).  Nevertheless, FasL is now recognized to 
be present on a broader range of leukocytes than originally 
thought,  e.g.,  mouse  CD8 +  DC  (45),  so  the  role  of this 
molecule, as well as membrane TNF  (46) known to be ex- 
pressed strongly on  macrophage  lineage cells, requires in- 
vestigation.  Studies  using  MG  derived from gld  mice  and 
also TNF-deficient mice recently produced by us  (unpub- 
lished observations)  are planned to  extend the work  done 
here in the rat model. It seems unlikely, however, that dif- 
ferential  expression  of these  molecules  alone  will  explain 
why non-MG  CNS  macrophages fully activate and main- 
tain survival of CD4 T  cells, while MG induce T  cell apop- 
tosis but at the same time support production by the T  cell of 
the  immunopathogenetically  relevant  cytokines  TNF  and 
IFN-%  In this context, it is important to note that the in- 
ability of exogenous  IL-2 in  MG-T  cell cultures to  restore 
proliferation (Fig. 3 A), the requirement for antigenic stimu- 
lus by MG before substantial apoptosis is induced (Fig. 4 A), 
and  the poor response  to  TCR.cross-linking of IL-2-res- 
cued  T  cells  after  MG  interaction  (Fig.  4  B),  all  argue 
strongly against the  simplistic explanation that  the  conse- 
quences of MG-T  cell interaction occur because MG lack 
the capacity to induce T  cell IL-2 production. 
In summary, the current findings support a role for fixed 
resident  macrophages  (in  this  case,  CNS  MG)  as  at  least 
one way of controlling T  cell responses in tissues, by induc- 
ing  an  immunological  "swan  song."  Such  a  mechanism 
could have a  dual purpose.  On the one hand,  it may con- 
tribute  to  surveillance  of tissues  like  the  CNS,  through 
controlled release by T  cells ofcytokines such as IFN-y and 
TNF, but not IL-2 in view of its proliferative potential. On 
the  other  hand,  it  represents  a  novel  way  of terminating 
unwanted  antiself  T  cell  responses  during  the  normal 
course  of immune  surveillance,  or within  disease-affected 
inflamed tissues. 
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